Gliptin-Induced Bullous Pemphigoid: Are Statins and Angiotensin Receptor Blockers the Cause?
This is one of the first studies to compare demographic, clinical, and laboratory characteristics of patients with gliptin-induced and conventional BP. Our results suggest gliptin-associated BP may present with more severe disease. Hyperlipidemia, ARB, and statin use may be associated with DPP4i-induced BP. Although larger studies are warranted to confirm this association, we believe these findings should be kept in mind while choosing patients to treat with gliptins.
Authors
- Burcu Beksaç (ORCID: https://orcid.org/0000-0001-5726-0696)
- Nilsel İlter (ORCID: https://orcid.org/0000-0001-7614-3102)
- Özlem Erdem (ORCID: https://orcid.org/0000-0002-5981-4856)
- Gözde Kubat (ORCID: https://orcid.org/0000-0002-0173-1054)
- Esra Adışen (ORCID: https://orcid.org/0000-0002-8768-231X)
- Sheyda Gharehdaghi (ORCID: https://orcid.org/0000-0002-0881-4485)
- Muhammed Kaan Temirkaynak (ORCID: https://orcid.org/0000-0002-3372-4342)
- Evren Atesci (ORCID: https://orcid.org/0009-0005-0545-8517)
Institutions
- Başkent University (TR)
- Gazi University (TR)
Publication Details
- Journal
- Dermatology and Therapy
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1007/s13555-025-01571-3
- Citations
- 1
- Primary Topic
- Autoimmune Bullous Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.47